Announced today that it offers finalized its contract with Zhejiang Huahai Pharmaceuticals Co.

The existing market is more than $100 million relating to industry data. Huahai received tentative authorization for Nevirapine Tablets by america Food and Drug Administration on July 10, 2007, and offers been distributing the product in Africa since that time under the PEPFAR plan . The U.S. Patent expires on May 22, 2012. Via an exclusive distribution and marketing agreement, Huahai and Breckenridge Pharmaceutical will launch the merchandise in the U.S. Upon patent expiration. Related StoriesSafe, effective douche-based rectal microbicide can prevent HIV in gay menResearch provides qualified prospects for new strategies to develop HIV vaccineStudy: Safe spaces may play vital role in community-structured HIV prevention effortsThe PEPFAR initiative encourages sponsors anywhere in the world to send U.S.Keep away from reach of children.

CTI deposits $10.6 million with U.S. Bank National Association, completes pension of 7.5 percent convertible senior notes Cell Therapeutics, Inc. today announced that it has deposited $10.6 million in cash as trust funds with U.S. Lender National Association, as the trustee of the outstanding 7.5 percent convertible senior notes , which is an amount enough to pay and discharge the entire amount due on the Notes, including accrued and unpaid interest. Bianco, M.D., CEO of CTI.

BMC anesthesiologist receives Letter of Commendation from Who all for pulse oximetry video Rafael Ortega, MD, an anesthesiologist at Boston INFIRMARY and vice-chairman of academic affairs at Boston University College of Medication , received a Letter of Commendation from the Globe Health Organization for creating a teaching video on pulse oximetry.